Vinicor-D 25 Tablet (Metoprolol Succinate 25mg / Chlorthalidone 6.25mg)

Description

VINICOR D 25 MG TABLET is a combination medicine used for the treatment of a mild to moderate increase in the blood pressure. Frequent monitoring of blood pressure and electrolytes levels is necessary during treatment with this medicine. Patients are advised to follow a strict exercise and diet regimen along with this medicine to get the best possible effect.

Substitutes

List of substitutes for VINICOR D 25 MG TABLET
REVELOL CH 25/6.25 MG TABLET
Ipca Laboratories Pvt. Ltd.

Side effects

Major & minor side effects for VINICOR D 25 MG TABLET
Very low blood pressure
Photosensitivity
Constipation
Diarrhea
Loss of appetite
Headache
Blurred vision
Restlessness
Chest pain and discomfort
Dizziness
Slow heart beat
Shortness of breath
Nausea or vomiting
Skin rash

Uses of VINICOR D 25 MG TABLET

What is it prescribed for?
Mild to moderate essential hypertension
This medicine is used to reduce high blood pressure caused by genetic and/or environmental factors.

Related Product

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to chlorthalidone, other sulfonamides, metoprolol, other beta-blockers, or any other inactive ingredients present along with these medicines.
Anuria
This medicine is not recommended for use in patients with anuria, a condition where the kidney is unable to produce urine.
Severe renal impairment
This medicine is not recommended for use in patients with severe renal impairment (CrCl < 30 ml/min) due to the increased risk of serious adverse effects.
Severe liver impairment
This medicine is not recommended for use in patients with severe liver impairment due to the increased risk of serious adverse effects.
Heart diseases
This medicine is not recommended for use in patients with serious heart problems such as a heart block, heart failure, sick sinus syndrome, etc. due to the increased risk of worsening of the patient’s condition.
Circulatory disorders
This medicine is not recommended for use in patients suffering from blood circulation disorders since it may worsen the patient’s condition.

Warnings

Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
General warnings
Volume and electrolyte disturbances
This medicine may alter the blood volume and electrolytes levels in some patients. This may cause dizziness, dry mouth, and acid-base imbalance. This risk is especially higher in patients suffering from kidney and liver diseases. Close monitoring of blood pressure and electrolytes levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Renal impairment
This medicine should be used with caution in patients with a known history of renal diseases due to the increased risk of worsening of the patient’s condition. Close monitoring of renal function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.
Driving or operating machines
This medicine may cause drowsiness or dizziness in some patients. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating heavy machinery during treatment with this medicine if you experience any of these symptoms.
Ischemic Heart Disease
This medicine should not be discontinued abruptly in patients suffering from ischemic heart disease since abrupt discontinuation may worsen the patient’s condition. The dosage should be reduced gradually over a period of 1 to 2 weeks along with close monitoring of heart function before discontinuation of therapy.
Major surgery
This medicine should be used with extreme caution in patients undergoing a major surgery due to the increased risk of severe adverse effects. Close monitoring of heart function is recommended for such patients.
Pheochromocytoma
This medicine should be administered with extreme caution in patients suffering from pheochromocytoma, a condition which results in an excess of a substance that controls heartbeat and blood pressure. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Bronchospastic Disease
This medicine should be administered with caution in patients with a disease of the lung or the airways leading to the lungs such as pneumonia, asthma, or chronic obstructive pulmonary disease. Close monitoring of lung function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Hyperthyroidism
This medicine should be administered with caution in patients suffering from hyperthyroidism since it may mask some of the patient’s symptoms. Close monitoring of thyroid hormone levels is recommended for such patients. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Heart Failure
This medicine may cause heart failure and reduced flow of blood in some patients. This risk is especially higher in patients with a history of heart diseases. Close monitoring of heart function and vital signs, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.
Peripheral Vascular Disease
This medicine should be used with caution in patients suffering from peripheral vascular diseases since it may worsen the patient’s condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Sports
Athletes are advised not to indulge in certain sports while using this medicine. Archery, racing, shooting and other high-risk sports should be avoided. Sportspersons should refer to the list of medicines published by World Anti-Doping Agency (WADA) which are not to be taken while participating in certain specific sports events.

Dosage

Missed Dose
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

General Instructions
Take this medicine exactly as advised by your doctor. Do not take in larger or smaller amounts than prescribed. It is advised to take this medicine at daytime to prevent sleep disturbance. Drink an adequate amount of water. Monitoring of kidney function and electrolytes levels is necessary while taking this medicine. Report any adverse effects to the doctor on priority. Do not stop the use of this medicine without consulting your doctor.